MARKET

REVBW

REVBW

Rvltn Bioscnc
NASDAQ
0.0099
0.0000
0.00%
Closed 09:30 08/27 EDT
OPEN
0.0099
PREV CLOSE
0.0099
HIGH
0.0099
LOW
0.0099
VOLUME
2.00K
TURNOVER
575
52 WEEK HIGH
0.0398
52 WEEK LOW
0.0050
MARKET CAP
--
P/E (TTM)
-0.0008
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at REVB last week (0817-0821)?
Weekly Report · 4d ago
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 08/20 21:06
Revelation Biosciences Grants Performance-Based Executive Stock Awards
TipRanks · 08/19 21:29
Revelation Biosciences Selected Avance Clinical To Serve As CRO For Phase 2/3 Adaptive-Design TITAN Study For Evaluating Gemini In Patients With Acute Kidney Injury
Benzinga · 08/19 13:05
Weekly Report: what happened at REVB last week (0810-0814)?
Weekly Report · 08/17 10:20
Weekly Report: what happened at REVB last week (0803-0807)?
Weekly Report · 08/10 10:15
Revelation Biosciences (REVB) Gets a Buy from Roth MKM
TipRanks · 08/07 18:25
Revelation Biosciences GAAP EPS of -$0.87
Seeking Alpha · 08/07 13:38
More
About REVBW
Revelation Biosciences, Inc. is a clinical-stage life sciences company engaged in the development of innate immune system therapeutics and diagnostics. Its therapeutic candidates are based on its Gemini formulation of active ingredient phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA) that is known to stimulate Toll-like receptor 4 (TLR-4). Its product candidates include Gemini-SSI, which is being developed for the prevention and treatment of surgical sit infection; Gemini-AKI, which is being developed as a potential therapy for the prevention and treatment of acute kidney injury as a result of cardiac surgery; and Gemini-CKD, which is being developed as a potential therapy for the prevention and treatment of chronic kidney disease. Stimulation of TLR4 via Gemini leads to a controlled production of varied cytokines and chemokines which modulate the activity of the innate and adaptive immune response, relative to Lipopolysaccharides (LPS).

Webull offers Revelation Biosciences Inc stock information, including NASDAQ: REVBW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REVBW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REVBW stock methods without spending real money on the virtual paper trading platform.